Literature DB >> 23707066

An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma.

Esther Rheinbay1, Mario L Suvà, Shawn M Gillespie, Hiroaki Wakimoto, Anoop P Patel, Mohammad Shahid, Ozgur Oksuz, Samuel D Rabkin, Robert L Martuza, Miguel N Rivera, David N Louis, Simon Kasif, Andrew S Chi, Bradley E Bernstein.   

Abstract

Glioblastoma (GBM) is thought to be driven by a subpopulation of cancer stem cells (CSCs) that self-renew and recapitulate tumor heterogeneity yet remain poorly understood. Here, we present a comparative analysis of chromatin state in GBM CSCs that reveals widespread activation of genes normally held in check by Polycomb repressors. These activated targets include a large set of developmental transcription factors (TFs) whose coordinated activation is unique to the CSCs. We demonstrate that a critical factor in the set, ASCL1, activates Wnt signaling by repressing the negative regulator DKK1. We show that ASCL1 is essential for the maintenance and in vivo tumorigenicity of GBM CSCs. Genome-wide binding profiles for ASCL1 and the Wnt effector LEF-1 provide mechanistic insight and suggest widespread interactions between the TF module and the signaling pathway. Our findings demonstrate regulatory connections among ASCL1, Wnt signaling, and collaborating TFs that are essential for the maintenance and tumorigenicity of GBM CSCs.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23707066      PMCID: PMC3774301          DOI: 10.1016/j.celrep.2013.04.021

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  59 in total

Review 1.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

Review 2.  Charting histone modifications and the functional organization of mammalian genomes.

Authors:  Vicky W Zhou; Alon Goren; Bradley E Bernstein
Journal:  Nat Rev Genet       Date:  2010-11-30       Impact factor: 53.242

Review 3.  Wnt/beta-catenin signaling in development and disease.

Authors:  Hans Clevers
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

4.  A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing.

Authors:  Joyce E Ohm; Kelly M McGarvey; Xiaobing Yu; Linzhao Cheng; Kornel E Schuebel; Leslie Cope; Helai P Mohammad; Wei Chen; Vincent C Daniel; Wayne Yu; David M Berman; Thomas Jenuwein; Kevin Pruitt; Saul J Sharkis; D Neil Watkins; James G Herman; Stephen B Baylin
Journal:  Nat Genet       Date:  2007-01-09       Impact factor: 38.330

5.  HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity.

Authors:  Virginie Clement; Pilar Sanchez; Nicolas de Tribolet; Ivan Radovanovic; Ariel Ruiz i Altaba
Journal:  Curr Biol       Date:  2006-12-28       Impact factor: 10.834

6.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

7.  High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment.

Authors:  Poonam Balani; Jerome Boulaire; Ying Zhao; Jieming Zeng; Jiakai Lin; Shu Wang
Journal:  Mol Ther       Date:  2009-02-24       Impact factor: 11.454

8.  Mapping and analysis of chromatin state dynamics in nine human cell types.

Authors:  Jason Ernst; Pouya Kheradpour; Tarjei S Mikkelsen; Noam Shoresh; Lucas D Ward; Charles B Epstein; Xiaolan Zhang; Li Wang; Robbyn Issner; Michael Coyne; Manching Ku; Timothy Durham; Manolis Kellis; Bradley E Bernstein
Journal:  Nature       Date:  2011-03-23       Impact factor: 49.962

9.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

10.  Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains.

Authors:  Manching Ku; Richard P Koche; Esther Rheinbay; Eric M Mendenhall; Mitsuhiro Endoh; Tarjei S Mikkelsen; Aviva Presser; Chad Nusbaum; Xiaohui Xie; Andrew S Chi; Mazhar Adli; Simon Kasif; Leon M Ptaszek; Chad A Cowan; Eric S Lander; Haruhiko Koseki; Bradley E Bernstein
Journal:  PLoS Genet       Date:  2008-10-31       Impact factor: 5.917

View more
  116 in total

1.  N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.

Authors:  Satoru Osuka; Dan Zhu; Zhaobin Zhang; Chaoxi Li; Christian T Stackhouse; Oltea Sampetrean; Jeffrey J Olson; G Yancey Gillespie; Hideyuki Saya; Christopher D Willey; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

2.  Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma.

Authors:  Andrew B Satterlee; Denise E Dunn; Donald C Lo; Simon Khagi; Shawn Hingtgen
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

3.  Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression.

Authors:  David Kozono; Jie Li; Masayuki Nitta; Oltea Sampetrean; David Gonda; Deepa S Kushwaha; Dmitry Merzon; Valya Ramakrishnan; Shan Zhu; Kaya Zhu; Hiroko Matsui; Olivier Harismendy; Wei Hua; Ying Mao; Chang-Hyuk Kwon; Hideyuki Saya; Ichiro Nakano; Donald P Pizzo; Scott R VandenBerg; Clark C Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-09       Impact factor: 11.205

4.  Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells.

Authors:  Cole Peters; Max Paget; Kizito-Tshitoko Tshilenge; Dipongkor Saha; Slawomir Antoszczyk; Anouk Baars; Thomas Frost; Robert L Martuza; Hiroaki Wakimoto; Samuel D Rabkin
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

5.  Cancer stem cells in glioma: challenges and opportunities.

Authors:  Jialiang Wang; Yufang Ma; Michael K Cooper
Journal:  Transl Cancer Res       Date:  2013-10-01       Impact factor: 1.241

6.  EGFR promoter exhibits dynamic histone modifications and binding of ASH2L and P300 in human germinal matrix and gliomas.

Authors:  Parsa Erfani; Jessica Tome-Garcia; Peter Canoll; Fiona Doetsch; Nadejda M Tsankova
Journal:  Epigenetics       Date:  2015-05-21       Impact factor: 4.528

7.  Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models.

Authors:  Jian Teng; Cintia C da Hora; Rami S Kantar; Ichiro Nakano; Hiroaki Wakimoto; Tracy T Batchelor; E Antonio Chiocca; Christian E Badr; Bakhos A Tannous
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

8.  ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state.

Authors:  Yakov Chudnovsky; Dohoon Kim; Siyuan Zheng; Warren A Whyte; Mukesh Bansal; Mark-Anthony Bray; Shuba Gopal; Matthew A Theisen; Steve Bilodeau; Prathapan Thiru; Julien Muffat; Omer H Yilmaz; Maya Mitalipova; Kevin Woolard; Jeongwu Lee; Riko Nishimura; Nobuo Sakata; Howard A Fine; Anne E Carpenter; Serena J Silver; Roel G W Verhaak; Andrea Califano; Richard A Young; Keith L Ligon; Ingo K Mellinghoff; David E Root; David M Sabatini; William C Hahn; Milan G Chheda
Journal:  Cell Rep       Date:  2014-01-16       Impact factor: 9.423

9.  Bivalent Chromatin Domains in Glioblastoma Reveal a Subtype-Specific Signature of Glioma Stem Cells.

Authors:  Amelia Weber Hall; Anna M Battenhouse; Haridha Shivram; Adam R Morris; Matthew C Cowperthwaite; Max Shpak; Vishwanath R Iyer
Journal:  Cancer Res       Date:  2018-03-16       Impact factor: 12.701

10.  Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion.

Authors:  Pedro Rosmaninho; Susanne Mükusch; Valerio Piscopo; Vera Teixeira; Alexandre Asf Raposo; Rolf Warta; Romina Bennewitz; Yeman Tang; Christel Herold-Mende; Stefano Stifani; Stefan Momma; Diogo S Castro
Journal:  EMBO J       Date:  2018-06-14       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.